For Individual Life Underwriting

An Independent Assessment of Milliman Irix® Risk Score 4.0 across Prescription Data, Medical Data, and Credit Data

Download our whitepapers for the study details:

Part 1: Proving the Power of 4.0 — Explore the mortality predictive power of Risk Score 4.0, key validation findings, and an introductory use case demonstrating real-world underwriting impact.

Upcoming:

• Part 2: Unlocking Additional Insights — Quantify the incremental value of prescription, medical, and credit data and discover how each data source enhances risk assessment and decision-making.
• Part 3: From Analytics to Results — Learn how carriers can leverage Risk Score 4.0 to optimize accelerated underwriting programs, refine threshold strategies, and drive better business outcomes.